Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Lommel, L" or (type any "bookEditor journalEditor issueEditor" and editor="Van Lommel...

Add to list
- Conference Paper
- C3
Mucosal gene expression profiling differentiates early from late ileal Crohn's disease

I Arijs, L Van Lommel, G De Hertogh, K Machiels, K Lemaire, Kristel Van Steen (UGent) , GA Van Assche, S Vermeire, FC Schuit and PJ Rutgeens

(2011) GASTROENTEROLOGY. 140(5, suppl. 1). p.S270-S270
Add to list
- Journal Article
- A1
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment

I Arijs, G De Hertogh, K Machiels, Kristel Van Steen (UGent) , K Lemaire, A Schraenen, L Van Lommel, R Quintens, G Van Assche, S Vermeire, et al.

(2011) AMERICAN JOURNAL OF GASTROENTEROLOGY. 106(4). p.748-761
Add to list
- Journal Article
- A1
Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

I Arijs, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, K Lemaire, A Schraenen, C Perrier, G Van Assche, S Vermeire, et al.

(2010) INFLAMMATORY BOWEL DISEASES. 16(12). p.2090-2098
Add to list
- Conference Paper
- C3
TECK and MADCAM-1 mucosal expression in active IBD : the effect of infliximab therapy

I Arijs, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, GA Van Assche, S Vermeire, K Geboes, FC Schuit and PJ Rutgeerts

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A207-A208
Add to list
- Conference Paper
- C3
The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease

I Arijs, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, GA Van Assche, S Vermeire, K Geboes, FC Schuit and PJ Rutgeerts

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A210-A210
Add to list
- Journal Article
- A1
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , P Leemans, G De Hertogh, K Lemaire, M Ferrante, et al.

(2009) GUT. 58(12). p.1612-1619
Add to list
- Conference Paper
- C3
Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease

I Arijs, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, M Ferrante, Marie Joossens (UGent) , K Geboes, GA Van Assche, S Vermeire, FC Schuit, et al.

(2008) GASTROENTEROLOGY. 134(4, suppl. 1). p.A117-A117
Add to list
- Conference Paper
- C3
Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment

I Arijs, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, R Quintens, K Lemaire, Marie Joossens (UGent) , FC Schuit, K Geboes, GA Van Assche, et al.

(2008) GASTROENTEROLOGY. 134(4, suppl. 1). p.A457-A457
Add to list
- Conference Paper
- C3
Gene expression profiling to predict the response of infliximab in patients with UC

I Arijs, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, F Schuit, K Geboes, G Van Assche, S Vermeire and PJ Rutgeerts

(2007) GASTROENTEROLOGY. 132(4, suppl. 2). p.A174-A174

Academic Bibliography

Mucosal gene expression profiling differentiates early from late ileal Crohn's disease

Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

TECK and MADCAM-1 mucosal expression in active IBD : the effect of infliximab therapy

The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease

Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment

Gene expression profiling to predict the response of infliximab in patients with UC

Contents

Support

Contact